PERCEIVE BIOTHERAPEUTICS

Serial Number 90723420
Registration 6896732
700

Registration Progress

Application Filed
May 20, 2021
Under Examination
May 3, 2022
Approved for Publication
Mar 8, 2022
Published for Opposition
Mar 8, 2022
Registered
Nov 8, 2022

Trademark Image

PERCEIVE BIOTHERAPEUTICS

Basic Information

Serial Number
90723420
Registration Number
6896732
Filing Date
May 20, 2021
Registration Date
November 8, 2022
Published for Opposition
March 8, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 8, 2022
Registration
Registered
Classes
042

Rights Holder

PERCEIVE BIOTHERAPEUTICS, INC.

03
Address
6000 SHORELINE CT., STE. 206
SOUTH SAN FRANCISCO, CA 94080

Ownership History

Oriole Therapeutics, Inc.

Original Applicant
03
Brisbane, CA

Oriole Therapeutics, Inc.

Owner at Publication
03
Brisbane, CA

PERCEIVE BIOTHERAPEUTICS, INC.

New Owner After Publication #1
03
SOUTH SAN FRANCISCO, CA

PERCEIVE BIOTHERAPEUTICS, INC.

Original Registrant
03
SOUTH SAN FRANCISCO, CA

Legal Representation

Attorney
J. Dickson Phillips, III

USPTO Deadlines

Next Deadline
1020 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20221108)
Due Date
November 08, 2028
Grace Period Ends
May 08, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Nov 8, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 8, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 5, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 4, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 4, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 3, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 23, 2022 IUAF S USE AMENDMENT FILED Loading...
Oct 3, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 23, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 3, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 23, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 23, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
May 25, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 3, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 8, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 8, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 16, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 1, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 1, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 1, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 1, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 1, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 1, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 17, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 24, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development; pharmaceutical research and development in the field of therapeutics for improving neuronal survival in neurodegenerative diseases
First Use Anywhere: Jun 29, 2021
First Use in Commerce: Jun 29, 2021

Additional Information

Pseudo Mark
PERCEIVE BIO THERAPEUTICS

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTHERAPEUTICS"